In order to be able to sell or purchase psychedelics, you must first obtain a Psychedelics Licence from Health Canada. A licensed dealer will be able to sell the controlled substance to a research institution or a company that is looking to conduct scientific research. While ketamine, a psychedelic used for recreational purposes, is already regulated under the Narcotic Control Regulations, it still needs a licence to be sold to the public. Currently, there are no licensed therapeutic psychedelic products available for general purchase in Canada. In 2017, Health Canada granted ayahuasca use for limited time to some religious organizations. This exemption had to be renewed in 2018, but is not yet available to the general public.

Not Be Commercially Available Yet

Currently, cannabis is classified as a Schedule 1 controlled substance in Canada, but the recent amendments to the SAP make it legal for individuals to consume it for recreational use. In addition to allowing psychedelics for recreational use, the Minister of Health continues to grant s. 56 exemptions. In Canada, however, psychedelics are still heavily regulated, so it is vital that companies involved in this industry remain aware of these legal issues and stay abreast of any developments in this field.

The psychedelics licensing process is quite complex, as there is a much larger regulatory framework than for cannabis. Cannabis has already been widely accepted by the adult recreational market, but psychedelics may have a longer testing period and higher costs. They may also not be commercially available yet. For now, there are no plans to market psychedelics, but a new law may change this. However, it is important to remember that the OHA has the power to revoke a license if the company does not follow OHA guidelines.